Related Experiment Video
Updated: May 28, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
[Gluten-free diet for children].
1Service de Gastroentérologie Pédiatrique, Hôpital des Enfants-Malades, 149 rue de Sèvres, 75743 Paris cedex, France. jacques.schmitz@nck.ap-hop-paris.fr
Pathologie-Biologie
|October 8, 2011
Summary
Children with celiac disease require adapted diets and long-term monitoring. Adults need lifelong gluten-free diets, while children may resume normal diets with strict follow-up to prevent adult complications.
Area of Science:
- Pediatric Gastroenterology
- Autoimmune Disorders
- Nutritional Science
Context:
- Celiac disease presents differently in children versus adults.
- Current management guidelines require adaptation for pediatric populations.
- Long-term outcomes and risks necessitate specific pediatric considerations.
Purpose:
- To outline adapted dietary and follow-up strategies for children with celiac disease.
- To differentiate management protocols for symptomatic, silent, and latent celiac disease in pediatric and adult populations.
- To establish guidelines for transitioning children to normal diets and reintroducing gluten later in life.
Summary:
- Children with celiac disease (CD) have distinct risk profiles compared to adults, necessitating tailored management.
- Symptomatic children require several years of a gluten-free diet (GFD), while adults need lifelong adherence.
- Children with silent CD may cautiously resume a normal diet with strict monitoring, restarting GFD at age 25 or during pregnancy to mitigate adult CD complications.
Impact:
- Provides evidence-based recommendations for pediatric celiac disease management.
- Aims to optimize long-term health outcomes for children diagnosed with celiac disease.
- Facilitates informed clinical decision-making regarding diet and follow-up for young celiac patients.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Taste Buds and Receptors
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:30Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...